Search Results - Kampylafka, Eleni

Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation - data from the prospective IVEPSA study

by Kampylafka, Eleni, Simon, David, d’Oliveira, Isabelle, Linz, Christina, Lerchen, Veronika, Englbrecht, Matthias, Rech, Juergen, Kleyer, Arnd, Sticherling, Michael, Schett, Georg, Hueber, Axel J.

Read online (freely available)
Order via interlibrary loan

Secukinumab leads to shifts from stage-based towards response-based disease clusters—comparative data from very early and established psoriatic arthritis

by Kampylafka, Eleni, Tascilar, Koray, Lerchen, Veronika, Linz, Christina, Sokolova, Maria, Zekovic, Ana, Kleyer, Arnd, Simon, David, Rech, Jürgen, Sticherling, Michael, Schett, Georg, Hueber, Axel J.

Read online (freely available)
Order via interlibrary loan

Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients

by Simon, David, Kleyer, Arnd, Bayat, Sara, Tascilar, Koray, Kampylafka, Eleni, Meinderink, Timo, Schuster, Louis, Petrov, Ramona, Liphardt, Anna-Maria 1978-, Rech, Juergen, Schett, Georg, Hueber, Axel J.

Read online (freely available)
Order via interlibrary loan

Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study

by Kampylafka, Eleni, d’Oliveira, Isabelle, Linz, Christina, Lerchen, Veronika, Stemmler, Fabian, Simon, David, Englbrecht, Matthias, Sticherling, Michael, Rech, Jürgen, Kleyer, Arnd, Schett, Georg, Hueber, Axel J.

Read online (freely available)
Order via interlibrary loan